Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108947819A reveals Pd-catalyzed deuteration. High purity over 98 percent, cost-effective solvent system for reliable supply chain.
Patent CN105348144B details a high-purity synthetic route for Simeprevir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced synthesis of 3-(7-amidino-2-naphthyl) derivatives via amidoxime reduction. Superior optical purity and scalable manufacturing for reliable API intermediate supply.
Novel copper-catalyzed oxidative cyclization method for 3-formyl-imidazo[1,2-a]pyridine. Reduces steps and improves yield for pharmaceutical intermediates.
Patent CN107721920B details a novel Rh(III)-catalyzed C(sp3)-H amidation. Offers high atom economy and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN115784916B reveals a mild neutral hydrogenation route for ACEI intermediates, eliminating corrosive acids and reducing equipment costs significantly.
Patent CN112125879A discloses a nickel-catalyzed Kumada coupling route for Canagliflozin intermediate. High yield, mild conditions, scalable industrial process reducing cost.
Novel oxidative coupling route for NSC128981 reduces toxic reagents. Enhances supply chain reliability for pharmaceutical intermediates manufacturing with high purity standards.
Patent CN112194620B reveals a high-purity route for ethionamide intermediates, eliminating isomers and ensuring cost reduction in API manufacturing.
Novel route for 3-chloro-5-iodophenol avoids expensive iridium catalysts. Safe, scalable manufacturing for HIV drug intermediates with high purity.
Patent CN108276267B details a novel synthesis for fluorine-containing 1,1-stilbene derivatives. This route offers enhanced metabolic stability and scalable manufacturing for oncology drug development.
Novel one-step synthesis of Crisaborole with high yield and purity. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced preparation method for Fasudil Hydrochloride via N-protected homopiperazine. Eliminates bis-sulfonyl byproducts, ensuring 99.99% purity and scalable manufacturing.
Advanced synthesis of Repaglinide intermediates via DEPBT coupling. Delivers high optical purity and cost reduction in API manufacturing for global supply chains.
Patent CN114573496B reveals a safe, scalable route for 4-chloroindole-3-acetic acid. Discover cost reduction and high-purity manufacturing advantages for pharmaceutical intermediates.
Patent CN105829284A reveals a rapid, water-based method for high-purity adamantane carboxamides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109020900A reveals high-yield 6-chloro-3-methyluracil synthesis improving supply chain stability and reducing manufacturing costs for global pharmaceutical intermediate buyers.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Novel Diels-Alder route for high-purity tranexamic acid. Reduces heavy metal residues and improves yield for API manufacturing.